Skip to main content
Journal ArticleOPEN ACCESS

Bedaquiline: a new weapon against MDR and XDR-TB

  • Singh H
  • Natt N
  • Garewal N
  • et al.
International Journal of Basic & Clinical Pharmacology (2013) 2(2) 96
DOI: 10.5455/2319-2003.ijbcp20130301
N/ACitations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Abstract Multidrug-resistant tuberculosis (MDR-TB) is a global public health problem. It requires treatment with combination therapy consisting of four to six drugs including combinations of bactericidal and bacteriostatic drugs, usually for a period of 2 years. ...

Cite

CITATION STYLE

APA

Singh, H., Natt, N., Garewal, N., & T, P. (2013). Bedaquiline: a new weapon against MDR and XDR-TB. International Journal of Basic & Clinical Pharmacology, 2(2), 96. https://doi.org/10.5455/2319-2003.ijbcp20130301

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free